Related Experiment Video

Updated: Nov 25, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.3K

Changes in Characteristics, Treatment and Outcome in Patients with Hemorrhagic Stroke During COVID-19

Yuqi Chen1, Fan Xia1, Yunke Li1

  • 1Department of Neurosurgery, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu, Sichuan 610041, P. R. China.

Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|December 18, 2020
PubMed

Insights

The COVID-19 pandemic impacted hemorrhagic stroke care, leading to longer treatment times and worse outcomes for moderate strokes. Process improvements may enhance patient recovery during public health crises.

Area of Science:

  • Neurology
  • Public Health
  • Epidemiology

Background:

  • The COVID-19 pandemic significantly disrupted global healthcare systems.
  • Understanding its specific impact on neurological conditions like hemorrhagic stroke is crucial.

Purpose of the Study:

  • To evaluate the effect of the COVID-19 pandemic on the treatment and prognosis of hemorrhagic stroke patients.
  • To compare outcomes between a pre-COVID-19 period and the early COVID-19 period in China.

Main Methods:

  • Retrospective analysis of hemorrhagic stroke patients admitted between January 24 and March 25 in 2019 (pre-COVID-19) and 2020 (COVID-19).
  • Comparison of clinical characteristics, door-to-department time, pneumonia rates, and 3-month modified Rankin Scale (mRS) scores.
  • Statistical analysis to determine significant differences between the two periods.

Main Results:

  • Fewer patients (126) were treated during the COVID-19 period compared to the pre-COVID-19 period (224).
  • Door-to-department time increased by approximately 50 minutes during the COVID-19 period (p=0.000).
  • Pneumonia complication rates rose significantly (40.6% vs. 60.7%, p=0.000), and good outcomes (mRS < 3) decreased for moderate strokes (53.1% vs. 26.3%, p=0.047).

Conclusions:

  • COVID-19 negatively influenced hemorrhagic stroke treatment and patient outcomes, particularly for moderate cases.
  • Delays in treatment and increased complications likely contributed to poorer prognoses.
  • Optimizing treatment pathways for moderate stroke patients is essential for improving outcomes during pandemics.
Abstract

Keywords:
Coronavirus diseaseOutcomePneumoniahemorrhagic stroke

More Related Videos

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia09:35

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia

Published on: November 15, 2024

689
A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

15.2K

Related Concept Videos

Regulation of Stroke Volume01:27

Regulation of Stroke Volume

The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
4.4K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
102
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
157